Dermata Therapeutics, Inc. (DRMA)
Sells acne and skin renewal creams directly to customers online
$1.24-0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-80.9%
The outlook
DRMA is trading near its 52-week low, well below both its 50- and 200-day moving averages. Analyst coverage leans bullish on longer-term potential, with the average price target implying significant upside from current levels, though the stock's recent trend remains weak. Overall sentiment is bearish based on current momentum indicators.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +224% vs current price
Market cap
$5.0M
52-wk high
$7.33
52-wk low
$1.10
50-day avg
$1.27
200-day avg
$1.94
Trailing P/E
—